These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 15379364

  • 1. A status report on the use of subantimicrobial-dose doxycycline: a review of the biologic and antimicrobial effects of the tetracyclines.
    Del Rosso JQ.
    Cutis; 2004 Aug; 74(2):118-22. PubMed ID: 15379364
    [No Abstract] [Full Text] [Related]

  • 2. Subantimicrobial dose doxycycline for acne and rosacea.
    Bikowski JB.
    Skinmed; 2003 Aug; 2(4):234-45. PubMed ID: 14673277
    [Abstract] [Full Text] [Related]

  • 3. The anti-inflammatory effects of tetracyclines.
    Weinberg JM.
    Cutis; 2005 Apr; 75(4 Suppl):6-11. PubMed ID: 15916224
    [Abstract] [Full Text] [Related]

  • 4. Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea.
    Song M, Seo SH, Ko HC, Oh CK, Kwon KS, Chang CL, Kim MB.
    J Dermatol; 2011 Jul; 38(7):667-73. PubMed ID: 21352337
    [Abstract] [Full Text] [Related]

  • 5. [In vitro resistance of Propionibacterium acnes and Staphylococcus epidermidis to antibiotics: should our antibiotic prescription practices for the treatment of acne be changed?].
    Bourgault-Villada I.
    Ann Dermatol Venereol; 1998 Dec; 125(12):879-80. PubMed ID: 9922858
    [No Abstract] [Full Text] [Related]

  • 6. Microbiological Profile of Sarecycline, a Novel Targeted Spectrum Tetracycline for the Treatment of Acne Vulgaris.
    Zhanel G, Critchley I, Lin LY, Alvandi N.
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397052
    [Abstract] [Full Text] [Related]

  • 7. [Treatment of acne vulgaris. A comparison of doxycycline versus minocycline].
    Laux B.
    Hautarzt; 1989 Sep; 40(9):577-81. PubMed ID: 2530191
    [Abstract] [Full Text] [Related]

  • 8. Use of systemic antibiotics in acne.
    Strauss JS.
    Acta Derm Venereol Suppl (Stockh); 1980 Sep; Suppl 89():71-3. PubMed ID: 6451129
    [No Abstract] [Full Text] [Related]

  • 9. Clinical use of a selective culture medium for wild and antibiotic-resistant Propionibacterium acnes.
    Marino C, Stoughton RB.
    J Am Acad Dermatol; 1982 May; 6(5):902-8. PubMed ID: 6212602
    [No Abstract] [Full Text] [Related]

  • 10. Propionibacterium acnes is developing gradual increase in resistance to oral tetracyclines.
    Nakase K, Nakaminami H, Takenaka Y, Hayashi N, Kawashima M, Noguchi N.
    J Med Microbiol; 2017 Jan; 66(1):8-12. PubMed ID: 28218057
    [Abstract] [Full Text] [Related]

  • 11. Recently approved systemic therapies for acne vulgaris and rosacea.
    Del Rosso JQ.
    Cutis; 2007 Aug; 80(2):113-20. PubMed ID: 17944168
    [Abstract] [Full Text] [Related]

  • 12. Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study.
    Dreno B, Foulc P, Reynaud A, Moyse D, Habert H, Richet H.
    Eur J Dermatol; 2005 Aug; 15(3):152-5. PubMed ID: 15908296
    [Abstract] [Full Text] [Related]

  • 13. Subantimicrobial dose doxycycline: a unique treatment for rosacea.
    Berman B, Zell D.
    Cutis; 2005 Apr; 75(4 Suppl):19-24. PubMed ID: 15916226
    [Abstract] [Full Text] [Related]

  • 14. Antibiotic resistance to Propionobacterium acnes: worldwide scenario, diagnosis and management.
    Sardana K, Gupta T, Garg VK, Ghunawat S.
    Expert Rev Anti Infect Ther; 2015 Jul; 13(7):883-96. PubMed ID: 26025191
    [Abstract] [Full Text] [Related]

  • 15. The role of tetracyclines in rosacea.
    Alikhan A, Kurek L, Feldman SR.
    Am J Clin Dermatol; 2010 Jul; 11(2):79-87. PubMed ID: 20141228
    [Abstract] [Full Text] [Related]

  • 16. Nasal antibiotic-resistant Propionibacterium acnes carriage in acne vulgaris patients in Turkey.
    Ergin C, Ergin S, Kaleli I, Kaçar N, Sengül M, Erdoğan BS.
    J Dermatol; 2006 Dec; 33(12):899-901. PubMed ID: 17169100
    [No Abstract] [Full Text] [Related]

  • 17. Subantimicrobial-dose doxycycline in the treatment of moderate facial acne.
    Toossi P, Farshchian M, Malekzad F, Mohtasham N, Kimyai-Asadi A.
    J Drugs Dermatol; 2008 Dec; 7(12):1149-52. PubMed ID: 19137768
    [Abstract] [Full Text] [Related]

  • 18. Clinical applications of non-antimicrobial tetracyclines in dermatology.
    Monk E, Shalita A, Siegel DM.
    Pharmacol Res; 2011 Feb; 63(2):130-45. PubMed ID: 20937386
    [Abstract] [Full Text] [Related]

  • 19. Tetracycline-resistant propionibacteria from acne patients are cross-resistant to doxycycline, but sensitive to minocycline.
    Eady EA, Jones CE, Gardner KJ, Taylor JP, Cove JH, Cunliffe WJ.
    Br J Dermatol; 1993 May; 128(5):556-60. PubMed ID: 8504049
    [Abstract] [Full Text] [Related]

  • 20. Tetracyclines: nonantibiotic properties and their clinical implications.
    Sapadin AN, Fleischmajer R.
    J Am Acad Dermatol; 2006 Feb; 54(2):258-65. PubMed ID: 16443056
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.